The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Sodium Phosphates
Sodium Phosphates · SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 276 mg/mL; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE 268 mg/mL · Injection, Solution · Intravenous · Caplin Steriles Limited
NDC 65145-0200-25 · 25 VIAL, SINGLE-DOSE in 1 CARTON / 5 mL in 1 VIAL, SINGLE-DOSE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- analysis · manufacture · pack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA220683
- TE code
- AP
- Approval date
- Feb 23, 2026
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Sodium Phosphates (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Caplin Steriles Limited | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 276 mg/mL; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE 268 mg/mL | Aug 26, 2026 | Sep 3, 2026 |
| Glenmark Pharmaceuticals Inc., Usa | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 276 mg/mL; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE 268 mg/mL | Aug 26, 2026 | Aug 31, 2026 |
| Glenmark Pharmaceuticals Inc., Usa | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 268 mg/mL; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE 276 mg/mL | Jul 22, 2026 | Aug 22, 2026 |
| Caplin Steriles Limited | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 268 mg/mL; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE 276 mg/mL | Jul 22, 2026 | Aug 21, 2026 |
| Caplin Steriles Limited | SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE 268 mg/mL; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 276 mg/mL | Jul 15, 2026 | Jul 19, 2026 |
| Glenmark Pharmaceuticals Inc., Usa | SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE 268 mg/mL; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 276 mg/mL | Jul 15, 2026 | Jul 16, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Sodium Phosphates — NDC 65145-0200-25," retrieved September 3, 2026, https://drugdashboards.com/drug/65145020025.
Free to cite with attribution — see how the data is put together.